EWCZ · European Wax Center, Inc.
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $73.3M | Fiscal Year 2025 | — |
| Adjusted EBITDA Margin non-GAAP | 35.5% | Fiscal Year 2025 | — |
| Adjusted Net Income non-GAAP | $36.2M | Fiscal Year 2025 | — |
| Same-store sales | 0.2% | Fiscal Year 2025 | — |
| System-wide sales | $947.3M | Fiscal Year 2025 | — |
| total centers | 1,047 | Fiscal Year 2025 | — |
| Closures | 31 | fiscal 2025 | — |
| Gross new center openings | 11 | fiscal 2025 | — |
| Net center closings | 20 | fiscal 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EWCZ
this stock
European Wax Center, Inc.
|
$319.14M | +61.7% | — | — | 1.4% |
|
PG
PROCTER & GAMBLE Co
|
$346.68B | +4.6% | +0.3% | 21.8 | 1.0% |
|
UL
Unilever PLC
|
$142.89B | -4.5% | — | — | 0.1% |
|
CL
Colgate Palmolive Co
|
$74.20B | +18.1% | +1.7% | 35.9 | 2.1% |
|
KVUE
Kenvue Inc.
|
$37.92B | +14.2% | -2.1% | 23.5 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EWCZ | +0.2% | +0.1% | +59.0% | +0.4% | +61.7% |
| SPY | +0.4% | +4.3% | +13.5% | +3.1% | +8.6% |
| vs SPY | -0.2% | -4.2% | +45.6% | -2.6% | +53.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.